| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2004 | CN1526394A Buspirone hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526393A Hydralazine hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526392A Cetirizine hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526391A Composition containing 5-[4-[2-(N-methyl-N-2-pyridyl)amino oxethyl] benzyl] thiazolidine-2, 4-diketone |
| 09/08/2004 | CN1526390A Piduomode granule and its prepn |
| 09/08/2004 | CN1526389A Application of 5,7,4'-substituted flavone in preparing medicine |
| 09/08/2004 | CN1526388A New use of 3,7,3'4'-substituted flavone |
| 09/08/2004 | CN1526387A Taxol vesicle injection and its prepn |
| 09/08/2004 | CN1526386A Houttuynin sodium powder injection and its prepn |
| 09/08/2004 | CN1526385A Ditropan hydrochloride dripping pills and the prepn process |
| 09/08/2004 | CN1526384A Quickly disintegrated fenofibrate oral prepn |
| 09/08/2004 | CN1526383A Jiafuming and Glibenclamide solid oral preparation and preparing method thereof |
| 09/08/2004 | CN1526382A Sertraline hydrochloride dripping pills and the prepn |
| 09/08/2004 | CN1526381A Application of small dosage anticholinesterase in preparing medicine for treating digestive system diseases caused by gastrointestinal motive disorder |
| 09/08/2004 | CN1526380A Metoprolol dripping pills and the prepn process thereof |
| 09/08/2004 | CN1526379A Sibutramine hydrochloride dripping pill and its prepn |
| 09/08/2004 | CN1526378A Application of effective rhubarb component in preparing medicine for strengthening AS2O3 to induce programmed tumor cell death |
| 09/08/2004 | CN1526377A Total emodin anthraquinone granule and its prepn and the prepn of dispersive Sanhuang tablet |
| 09/08/2004 | CN1165617C Oligonucleotides for inhibiting expression of human eg5 |
| 09/08/2004 | CN1165551C Viva pertusa polyose for regulating blood fat and its preparing method |
| 09/08/2004 | CN1165550C Synthetic polysaccharides, their method of prodn. and pharmaceutical compositions contg. same |
| 09/08/2004 | CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 09/08/2004 | CN1165546C New derivative of erythromycin, its preparation method and medicinal application |
| 09/08/2004 | CN1165545C Method for separating and extracting total flavone from goldenrain tree plant and its application |
| 09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
| 09/08/2004 | CN1165538C Tert-butoxy carbonyl dihydro artemisinin, preparation method and drug composition thereof |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/08/2004 | CN1165535C Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 09/08/2004 | CN1165534C Heterocyclyl amino methyloxazolidinones as antibacterials |
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
| 09/08/2004 | CN1165526C Substituted phenyl cyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165509C Gronwell naphthaquinone derivative and its application in preparing anticancer medicine |
| 09/08/2004 | CN1165345C Prucalopride oral solution and preparing method thereof |
| 09/08/2004 | CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165338C Endoparasiticidal compositions |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165335C Compound preparation for curing diarrhea |
| 09/08/2004 | CN1165329C Exterior-applied antalgic medicine and its preparing process |
| 09/08/2004 | CN1165322C Medicine for curing gastritis, gastric and duodenal ulcer |
| 09/08/2004 | CN1165320C Externally applied medicine for treating cervical erosion and its prepn |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/08/2004 | CN1165314C Use of polylactic mixture in preparation of treatment |
| 09/08/2004 | CN1165313C Slowly released clamycin capsule |
| 09/08/2004 | CN1165312C Hydrosterol composition and use thereof |
| 09/08/2004 | CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process |
| 09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
| 09/08/2004 | CN1165309C Stable compositions comprising levosimendan and alginic acid |
| 09/08/2004 | CN1165308C Compositions and method for reducing respiratory depression and attendant side effect of mu opioid compounds |
| 09/08/2004 | CN1165307C Controlled release oxycodone compositions |
| 09/08/2004 | CN1165306C Cold resisting compound medicinal composition |
| 09/08/2004 | CN1165305C Lyophilized composition of nimodipine |
| 09/08/2004 | CN1165304C Nimudipin undertongue spraying agent |
| 09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 09/08/2004 | CN1165302C Medical use of andrographolide and its derivatives |
| 09/08/2004 | CN1165301C Use of compositions for preparing anticancer medicines |
| 09/08/2004 | CN1165300C Parenteral paclitaxel stable non-toxic formulation |
| 09/08/2004 | CN1165299C Composition for treatment of psoriasis |
| 09/08/2004 | CN1165298C New use of compounds as antibacterial agents |
| 09/08/2004 | CN1165296C Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or film-forming auxiliary agent |
| 09/08/2004 | CN1165295C Controlled-release compositions of betahistine |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/08/2004 | CN1165291C Anti-fungus composition with improved biological utilization rate |
| 09/08/2004 | CN1165290C New medicine release system-liposolubility medicinal preparation |
| 09/08/2004 | CN1165289C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 09/08/2004 | CN1165287C Compositions contg. antifungal and cationic agent |
| 09/07/2004 | US6787675 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787653 Reacting, in the presence of a metal catalyst, a halogenobenzoic acid derivative with benzene derivative to produce biphenyldicarboxylic acid amide derivative |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787573 Antiviral therapy |
| 09/07/2004 | US6787572 Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies |
| 09/07/2004 | US6787569 Therapeutic guanidines |
| 09/07/2004 | US6787568 Antibiotic/analgesic formulation and a method of making this formulation |
| 09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
| 09/07/2004 | US6787563 Antidiarrhea agents; gastrointestinal disorders |
| 09/07/2004 | US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787553 Sexual disorders; vasodilation |
| 09/07/2004 | US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787548 Cardiovascular insufficiency and erectile dysfunction; 3-(4-(3-chloro-4-hydroxybenzylamino) benzo(4,5)thieno(2,3-d)pyrimidin-2-yl)propionic acid |
| 09/07/2004 | US6787547 Compound and method for the treatment of pain |
| 09/07/2004 | US6787546 Heterocycle derivatives and drugs |
| 09/07/2004 | US6787544 Useful for prophylaxis and therapy of virus infections and especially influenza virus infections |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787541 Thieno-and furopyrimidine derivatives as A2A-receptor antagonists |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |